Details
| Stereochemistry | ACHIRAL |
| Molecular Formula | C13H21N5O2.ClH |
| Molecular Weight | 315.799 |
| Optical Activity | NONE |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Charge | 0 |
SHOW SMILES / InChI
SMILES
Cl.CCN(CC)CCN1C=NC2=C1C(=O)N(C)C(=O)N2C
InChI
InChIKey=WZNIVRAEOQQUIB-UHFFFAOYSA-N
InChI=1S/C13H21N5O2.ClH/c1-5-17(6-2)7-8-18-9-14-11-10(18)12(19)16(4)13(20)15(11)3;/h9H,5-8H2,1-4H3;1H
| Molecular Formula | C13H21N5O2 |
| Molecular Weight | 279.3381 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
| Molecular Formula | ClH |
| Molecular Weight | 36.461 |
| Charge | 0 |
| Count |
|
| Stereochemistry | ACHIRAL |
| Additional Stereochemistry | No |
| Defined Stereocenters | 0 / 0 |
| E/Z Centers | 0 |
| Optical Activity | NONE |
Approval Year
PubMed
| Title | Date | PubMed |
|---|---|---|
| Identification of etamiphylline and metabolites in equine plasma and urine by accurate mass and liquid chromatography/tandem mass spectrometry. | 2010-06 |
|
| N-deethylation and N-oxidation of etamiphylline: identification of etamiphylline-N-oxide in greyhound urine by high performance liquid chromatography-mass spectrometry. | 2005-01-04 |
|
| The pharmacokinetics, metabolism and urinary detection time of etamiphylline in camels after intramuscular administration. | 2002-02 |
| Substance Class |
Chemical
Created
by
admin
on
Edited
Mon Mar 31 18:38:53 GMT 2025
by
admin
on
Mon Mar 31 18:38:53 GMT 2025
|
| Record UNII |
66ZCZ8Z4HE
|
| Record Status |
Validated (UNII)
|
| Record Version |
|
-
Download
| Name | Type | Language | ||
|---|---|---|---|---|
|
Common Name | English | ||
|
Preferred Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English | ||
|
Common Name | English | ||
|
Common Name | English | ||
|
Systematic Name | English |
| Code System | Code | Type | Description | ||
|---|---|---|---|---|---|
|
241-204-1
Created by
admin on Mon Mar 31 18:38:53 GMT 2025 , Edited by admin on Mon Mar 31 18:38:53 GMT 2025
|
PRIMARY | |||
|
28328
Created by
admin on Mon Mar 31 18:38:53 GMT 2025 , Edited by admin on Mon Mar 31 18:38:53 GMT 2025
|
PRIMARY | |||
|
100000153548
Created by
admin on Mon Mar 31 18:38:53 GMT 2025 , Edited by admin on Mon Mar 31 18:38:53 GMT 2025
|
PRIMARY | |||
|
C007635
Created by
admin on Mon Mar 31 18:38:53 GMT 2025 , Edited by admin on Mon Mar 31 18:38:53 GMT 2025
|
PRIMARY | |||
|
17140-68-0
Created by
admin on Mon Mar 31 18:38:53 GMT 2025 , Edited by admin on Mon Mar 31 18:38:53 GMT 2025
|
PRIMARY | |||
|
m5036
Created by
admin on Mon Mar 31 18:38:53 GMT 2025 , Edited by admin on Mon Mar 31 18:38:53 GMT 2025
|
PRIMARY | Merck Index | ||
|
66ZCZ8Z4HE
Created by
admin on Mon Mar 31 18:38:53 GMT 2025 , Edited by admin on Mon Mar 31 18:38:53 GMT 2025
|
PRIMARY | |||
|
SUB127700
Created by
admin on Mon Mar 31 18:38:53 GMT 2025 , Edited by admin on Mon Mar 31 18:38:53 GMT 2025
|
PRIMARY | |||
|
DTXSID40169089
Created by
admin on Mon Mar 31 18:38:53 GMT 2025 , Edited by admin on Mon Mar 31 18:38:53 GMT 2025
|
PRIMARY |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
PARENT -> SALT/SOLVATE |
| Related Record | Type | Details | ||
|---|---|---|---|---|
|
|
ACTIVE MOIETY |